{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:24:59Z","timestamp":1760783099618,"version":"build-2065373602"},"reference-count":28,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1996,3]]},"abstract":"<jats:p>Ovarian cancer is the fifth most common malignancy in women in the UK. Patients with a family history including ovarian cancer make up nearly 15% of family cancer referrals to the Genetic Clinic in Aberdeen. To date, only one pedigree has been suitable for linkage studies, which has enabled us to target screening more accurately at those people at highest risk. Following discovery of a strong candidate for the BRCA1 gene, direct mutation testing may soon be possible. People who seek testing will require further counselling. Therefore we anticipate an increased demand on both clinical and laboratory resources, but more accurate ascertainment of high risk subjects should lead to more appropriate targeting of screening services.<\/jats:p>","DOI":"10.1136\/jmg.33.3.187","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"187-192","source":"Crossref","is-referenced-by-count":1,"title":["Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic."],"prefix":"10.1136","volume":"33","author":[{"given":"H","family":"Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Semper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Haites","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1996,3,1]]},"reference":[{"article-title":"Epidemiology and aetiology of ovarian cancer: a review. Obstet Gynecol 1985; 66: 127-35. style similar to other adult onset genetic disorders, such as Huntington's disease.28 Because","author":"Heintz, A.P.M.; Hacker, N.F.; Lagasse, L.D.","key":"ref_1","unstructured":"Heintz APM, Hacker NF, Lagasse LD, et al. Epidemiology and aetiology of ovarian cancer: a review. Obstet Gynecol 1985;66: 127-35. style similar to other adult onset genetic disorders, such as Huntington's disease.28 Because"},{"key":"ref_2","first-page":"238","article-title":"Annual report on the results of treatment in gynaecological cancer","volume":"36","author":"Petterson, F.","year":"1991","unstructured":"Petterson F. Annual report on the results of treatment in gynaecological cancer. Int J Gynaecol Obstet 1991; 36(suppl):238-77. of this, it has been suggested that a similar programme of counselling should be available for those at possible high risk of developing an inherited cancer syndrome, for which genetic","journal-title":"Int J Gynaecol Obstet; of this, it has been suggested that a similar programme of counselling should be available for those at possible high risk of developing an inherited cancer syndrome, for which genetic"},{"key":"ref_3","first-page":"589","article-title":"Surveillance and maniagement of patients at high genetic risk for ovarian cancer","volume":"59","author":"Lynch, H.T.; Albano, W.A.; Lynch, J.F.","year":"1982","unstructured":"Lynch HT, Albano WA, Lynch JF, et al. Surveillance and maniagement of patients at high genetic risk for ovarian cancer. Obstet Gynecol 1982;59:589-96.","journal-title":"Obstet Gynecol"},{"key":"ref_4","first-page":"3","article-title":"Risk of ovarian cancer associated with a family history: preliminary report of the OPCS study","volume-title":"cancer - biological and therapeuttic challeniges","author":"Ponder, B.A.J.; Easton, D.F.","unstructured":"Ponder BAJ, Easton DF. Risk of ovarian cancer associated with a family history: preliminary report of the OPCS study. In: Sharp F, Mason WP, Leake RE, eds. Ovarian cancer - biological and therapeuttic challeniges. London: Chapman & Hall Medical, 1989:3-6."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jmg.29.6.416","article-title":"Ovarian cancer family and prophylactic choices","volume":"29","author":"Evans, D.G.R.; Ribiero, G.; Warrell, D.","year":"1992","unstructured":"Evans DGR, Ribiero G, Warrell D, et al. Ovarian cancer family and prophylactic choices. _7 Med Genet 1992;29: 416-8.","journal-title":"_7 Med Genet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki, Y.; Swensen, J.; Shattuck-Eidens, D.","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.","journal-title":"Science"},{"key":"ref_7","first-page":"120","article-title":"BRCA 1 mutations in primary breast and ovarian carcinomas","volume":"226","author":"Futreal, P.A.; Liu, Q.; Shattuck-Eidens, D.","year":"1994","unstructured":"Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA 1 mutations in primary breast and ovarian carcinomas. Science 1994;226: 120-2.","journal-title":"Science"},{"key":"ref_8","article-title":"Clinical protocol for 17q predictive testing in breast\/ovarian families. Draft protocol for consideration by","author":"Eeles, R.; Ponder, B.; Easton, D.","year":"1993","unstructured":"Eeles R, Ponder B, Easton D, et al. Clinical protocol for 17q predictive testing in breast\/ovarian families. Draft protocol for consideration by, CFSG, December 1993."},{"key":"ref_9","first-page":"226","article-title":"The multidisciplinary management of a family with epithelial ovarian cancer. Br_7 Obstet Gytnaecol","volume":"99","author":"Cruickshank, D.J.; Haites, N.; Anderson, S.","year":"1992","unstructured":"Cruickshank DJ, Haites N, Anderson S, et al. The multidisciplinary management of a family with epithelial ovarian cancer. Br_7 Obstet Gytnaecol 1992;99:226-31."},{"key":"ref_10","first-page":"761","article-title":"Linkage studies with 17q and 18q markers in a breast\/ovarian cancer family","volume":"52","author":"Milner, B.J.; Allan, L.A.; Kelly, K.F.","year":"1993","unstructured":"Milner BJ, Allan LA, Kelly KF, et al. Linkage studies with 17q and 18q markers in a breast\/ovarian cancer family. Amii _Hunz Genet 1993;52:761-6.","journal-title":"Amii _Hunz Genet"},{"key":"ref_11","first-page":"335","article-title":"Non-surgical aspects of ovarian cancer. Report of a Meeting of Physicians and Scientists","author":"Ponder, B.","year":"1994","unstructured":"Ponder B. Non-surgical aspects of ovarian cancer. Report of a Meeting of Physicians and Scientists, Institute of Cancer Research and the Royal Marsden Hospital, London. Lancet 1994,343:335-40.","journal-title":"Institute of Cancer Research and the Royal Marsden Hospital, London. Lancet"},{"key":"ref_12","first-page":"2015","article-title":"Genetic counselling in the cancer family clinic","volume":"30","author":"Murday, V.","year":"1994","unstructured":"Murday V. Genetic counselling in the cancer family clinic. Eur 7Cancer 1994;30A:2015-29."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1399-0004.1992.tb03407.x","article-title":"One hundred requests for predictive testing for Huntington's disease","volume":"41","author":"Simpson, S.A.; Besson, J.; Alexander, D.","year":"1992","unstructured":"Simpson SA, Besson J, Alexander D, et al. One hundred requests for predictive testing for Huntington's disease. Clin Genet 1992;41:326-30.","journal-title":"Clin Genet"},{"key":"ref_14","first-page":"148","article-title":"A case study of carcinoma of the ovary","volume":"31","author":"Newhouse, M.L.; Pearson, R.M.; Fullerton, J.M.","year":"1977","unstructured":"Newhouse ML, Pearson RM, Fullerton JM, et al. A case study of carcinoma of the ovary. Br]I Prev Soc Med 1977; 31: 148-52.","journal-title":"Br]I Prev Soc Med"},{"key":"ref_15","first-page":"650","article-title":"The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl 3 Med 1987,316","author":"Cancer; Group, Steroid Hormone Study","unstructured":"Cancer and Steroid Hormone Study Group. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl 3 Med 1987,316:650-5."},{"key":"ref_16","first-page":"973","article-title":"Oral contraceptive use and breast cancer risk in young women","volume":"i:","author":"UK National Cancer Control Study Group","year":"1989","unstructured":"UK National Cancer Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;i:973-82.","journal-title":"Lancet"},{"key":"ref_17","first-page":"80","article-title":"Oral contraceptives in relation to breast cancer","volume":"15","author":"Malone, K.E.; Daling, JR, Weiss; N.S.","year":"1993","unstructured":"Malone KE, Daling JR, Weiss NS. Oral contraceptives in relation to breast cancer. Epidenliol Rezv 1993;15:80-97.","journal-title":"Epidenliol Rezv"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bmj.306.6884.1025","article-title":"Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging","volume":"306","author":"Bourne, T.H.; Campbell, S.; Reynolds, K.M.","year":"1993","unstructured":"Bourne TH, Campbell S, Reynolds KM, et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 1993; 306:1025-9.","journal-title":"BMJ"},{"key":"ref_19","first-page":"14","article-title":"Prospective evaluation of serum CA125 levels for early detection of ovarian cancer","volume":"80","author":"Einhorn, N.; Sjovall, K.; Knapp, R.C.","year":"1992","unstructured":"Einhorn N, Sjovall K, Knapp RC, et al. Prospective evaluation of serum CA125 levels for early detection of ovarian cancer. Obstet Gynecol 1992;80:14-18.","journal-title":"Obstet Gynecol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/bmj.306.6884.1030","article-title":"Prevalence screening for ovarian cancer in post-menopausal women by CA125 measurement and ultrasonography","volume":"306","author":"Jacobs, I.; Prys Davies, A.; Bridges, J.","year":"1993","unstructured":"Jacobs I, Prys Davies A, Bridges J, et al. Prevalence screening for ovarian cancer in post-menopausal women by CA125 measurement and ultrasonography. BMJ 1993;306:1030-4.","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families","volume":"ii:","author":"Tobacman, J.K.; Green, M.H.; Tucker, M.A.","year":"1982","unstructured":"Tobacman JK, Green MH, Tucker MA, et al. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families. Lancet 1982;ii:795-7.","journal-title":"Lancet"},{"issue":"3","key":"ref_22","first-page":"93","article-title":"Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome","volume":"66","author":"Chen, K.T.K.; Schooley, J.L.; Flam, M.S.","year":"1985","unstructured":"Chen KTK, Schooley JL, Flam MS. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gy,necol 1985;66(suppl 3):93-4S.","journal-title":"Obstet Gy, necol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.8484120","article-title":"Genetic mapping of a locus predisposing to human colorectal cancer","volume":"260","author":"Peltomaki, P.; Aaltonen, L.A.; Sistonen, P.","year":"1993","unstructured":"Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Scienice 1993;260:810-12.","journal-title":"Scienice"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","article-title":"The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer","volume":"75","author":"Fishel, R.; Lescoe, M.K.; Rao, M.R.S.","year":"1993","unstructured":"Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75: 1027-38.","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0092-8674(93)90330-S","article-title":"Mutations of a miiutS homology in hereditary nonpolyposis colorectal cancer","volume":"75","author":"Leach, F.S.; Nicolaides, N.C.; Papadopoulos, N.","year":"1993","unstructured":"Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a miiutS homology in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.8128251","article-title":"Mutation of a nzutL homolog in hereditary colon cancer","volume":"263","author":"Papadopolous, N.; Nicolaides, N.C.; Nei, Y.F.","year":"1994","unstructured":"Papadopolous N, Nicolaides NC, Nei YF, et al. Mutation of a nzutL homolog in hereditary colon cancer. Science 1994;263:1625-9.","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localisation of a breast cancer susceptibility gene BRCA2 to chromosome 13q 12-13","volume":"265","author":"Wooster, R.; Neuhausen, S.; Mangion, J.","year":"1994","unstructured":"Wooster R, Neuhausen S, Mangion J, et al. Localisation of a breast cancer susceptibility gene BRCA2 to chromosome 13q 12-13. Science 1994;265:2088-90.","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.308.6927.535","article-title":"Genetic prediction of adult onset disease","volume":"308","author":"Simpson, S.A.; Dean, J.C.S.; Haites, N.E.","year":"1994","unstructured":"Simpson SA, Dean JCS, Haites NE. Genetic prediction of adult onset disease. BMJ 1994;308:535.","journal-title":"BMJ"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.33.3.187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:41:53Z","timestamp":1760737313000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.33.3.187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1996,3,1]]},"published-print":{"date-parts":[[1996,3]]}},"alternative-id":["10.1136\/jmg.33.3.187"],"URL":"https:\/\/doi.org\/10.1136\/jmg.33.3.187","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}